[{"indications": "Indications\u00a0treatment of acute migraine; cluster headache\r\n(nasal route only) [unlicensed use]", "name": "ZOLMITRIPTAN", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.7 Analgesics", "4.7.4 Antimigraine drugs", "4.7.4.1 Treatment of acute migraine", "5HT1-receptor agonists"], "cautions": "Cautions\u00a0see under 5HT1-receptor agonists above; should not be taken within 24 hours of any other 5HT1-receptor\r\nagonist; interactions: Appendix 1 (5HT1 agonists)", "side-effects": "Side-effects\u00a0see under 5HT1-receptor\r\nagonists above; also abdominal pain, dry mouth; palpitation;\r\ndrowsiness, paraesthesia, headache; myalgia, muscle weakness; less commonly tachycardia, transient increase in blood pressure,\r\npolyuria; rarely urticaria; very rarely gastro-intestinal and splenic infarction, ischaemic colitis, angina,\r\nmyocardial infarction; with nasal spray, taste disturbance,\r\nand epistaxis", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/61033.htm", "doses": ["By mouth, migraine, adult over 18 years, 2.5\u00a0mg repeated after not less than 2 hours if migraine\r\nrecurs (increase to 5\u00a0mg for subsequent attacks in patients not achieving\r\nsatisfactory relief with 2.5-mg dose); max. 10\u00a0mg in 24 hours; child 12\u201318 years see BNF for Children", "Intranasally, cluster headache [unlicensed] or\r\nmigraine, adult over 18 years, 5\u00a0mg\r\n(1 spray) into one nostril as soon as possible after onset, repeated\r\nafter not less than 2 hours if headache recurs; max. 10\u00a0mg in 24 hours; child 12\u201318 years see BNF for Children", "Max. 5\u00a0mg in 24 hours with concomitant cimetidine,\r\nfluvoxamine, moclobemide, or quinolone antibiotics"], "pregnancy": "Pregnancy\u00a0\n(From 5HT1-receptor agonists: British National Formulary)\nPregnancy\u00a0There is limited experience of using 5HT1-receptor agonists during pregnancy; manufacturers advise that they should be avoided unless the potential benefit outweighs the risk."}]